Get started
Author

Ó Moralejo Lozano

Observed names: O Moralejo Lozano, O. Moralejo Lozano
ORCID: 0000-0002-4808-6363
Observed ORCID: 0000-0002-4808-6363
OpenAlex ID: A5123502434
Post‐Operative Recurrence of Colonic Crohn's Disease After Colectomy: The RESECOL Study by the Young Group of GETECCU
2026 · J. L. Rueda García, C. Suárez Ferrer, et al. · Alimentary Pharmacology & Therapeutics · 4
DOP032 Comparative study on the effectiveness, durability, and safety of upadacitinib versus risankizumab after anti-TNF failure in Crohn’s Disease: The U-PARIS study of ENEIDA
2026 · C Rubín De Célix, A Granja, et al. · Journal of Crohn s and Colitis · 2
P829 Clostridioides difficile infection in patients using vedolizumab and antiTNF: incidence and consequences (CDIFVEDO study of GETECCU)
2024 · M Gonzalez Vivo, G Font Ordeig, et al. · Journal of Crohn s and Colitis · 2
PDF
P0907 Short-term effectiveness and safety of Mirikizumab in ulcerative colitis: real-world evidence from the ENEIDA registry of GETECCU
2026 · A Gutiérrez Casbas, M Barreiro-de Acosta, et al. · Journal of Crohn s and Colitis · 1
P0724 Efficacy and safety of granulocyte and monocyte apheresis (GMA) with Adacolumn® in patients with inflammatory bowel disease in real-world practice in Spain: the GRACE study.
2026 · I Rodríguez-Lago, J L Cabriada Nuno, et al. · Journal of Crohn s and Colitis · 1
PDF
P0572 Subcutaneous infliximab (CT-P13) in Inflammatory Bowel Disease: Real-World Effectiveness and Safety. Observational retrospective single tertiary centre study.
2026 · J V Cárdenas Patiño, Ó Moralejo Lozano, et al. · Journal of Crohn s and Colitis
PDF
P0287 Small bowel capsule endoscopy and ileocolonoscopy for activity grading in ileal Crohn’s disease, a comparative analysis. Results from the CAPITER study, a multicenter study from the Young GETECCU Group
2026 · M Marquès-Camí, L Vergés, et al. · Journal of Crohn s and Colitis
P0256 Quality of screening for human papillomavirus in women with inflammatory bowel disease (EII-VIP ENEIDA study)
2026 · A Artero, P Borras Garriga, et al. · Journal of Crohn s and Colitis
P0791 Real-World One-year Effectiveness of Risankizumab in Crohn’s Disease: Clinical, Biochemical and Ultrasound responses. A single-centre, observational, retrospective study.
2026 · Ó Moralejo Lozano, V C Jarrín Pesantes, et al. · Journal of Crohn s and Colitis
P0721 Predictors of long-term clinical remission with risankizumab in patients with Crohn’s disease. A single centre, observational, retrospective study: a regression analysis.
2026 · Ó Moralejo Lozano, V C Jarrín Pesantes, et al. · Journal of Crohn s and Colitis
PDF
P0446 Diagnostic performance of the Clinical Decision Support Tool score in Vedolizumab-treated Crohńs Disease patients (VDZ-CDST): A single-centre, observational, retrospective study
2026 · A Flores, Ó Moralejo Lozano, et al. · Journal of Crohn s and Colitis
PDF
P0283 Assessment of the ultrasound response to risankizumab at weeks 12 and 52 in patients with Crohn’s disease. A single centre, observational, retrospective study.
2026 · Ó Moralejo Lozano, V C Jarrín Pesantes, et al. · Journal of Crohn s and Colitis
PDF
P1105 Switching to Subcutaneous Infliximab for Regaining Clinical Remission in Inflammatory Bowel Disease Patients who lost response to Intravenous Infliximab: An Observational Study from the ENEIDA Registry
2026 · E Brunet, A Altadill, et al. · Journal of Crohn s and Colitis
P0293 Vedolizumab persistence in Crohn’s Disease. Survival analysis: a single centre observational retrospective study. Is the Clinical Decision Support Tool (VDZ-CDST) associated to persistence?
2026 · Ó Moralejo Lozano, A Flores, et al. · Journal of Crohn s and Colitis
Works count: 14
Citation count: 10
H-index: 2
I10-index:
Year
Topic
Type